These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis. Molica S; Giannarelli D; Montserrat E Eur J Haematol; 2022 Mar; 108(3):264-267. PubMed ID: 34856031 [No Abstract] [Full Text] [Related]
3. Effects of the BTN162b2 mRNA COVID-19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia. Fiorcari S; Atene CG; Maffei R; Mesini N; Debbia G; Colasante C; Pozzi S; Barbieri E; Maccaferri M; Leonardi G; Potenza L; Luppi M; Marasca R Hematol Oncol; 2023 Feb; 41(1):120-127. PubMed ID: 36156278 [TBL] [Abstract][Full Text] [Related]
4. Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia. Morawska M Eur J Haematol; 2022 Feb; 108(2):91-98. PubMed ID: 34717004 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia. Mellinghoff SC; Mayer L; Robrecht S; Weskamm LM; Dahlke C; Gruell H; Schlotz M; Vanshylla K; Schloser HA; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Eichhorst B; Hallek M; Langerbeins P Haematologica; 2022 Oct; 107(10):2480-2484. PubMed ID: 35734927 [No Abstract] [Full Text] [Related]
6. COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients. Del Poeta G; Bomben R; Polesel J; Rossi FM; Pozzo F; Zaina E; Cattarossi I; Varaschin P; Nanni P; Boschian Boschin R; Postorino M; Laureana R; Pasqualone G; Steffan A; Gentile M; Zucchetto A; Gattei V Hematol Oncol; 2021 Dec; 39(5):712-714. PubMed ID: 34462939 [No Abstract] [Full Text] [Related]
7. Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia. Lyski ZL; Kim MS; Xthona Lee D; Raué HP; Raghunathan V; Griffin J; Ryan D; Brunton AE; Curlin ME; Slifka MK; Messer WB; Spurgeon SE Blood Adv; 2022 Feb; 6(4):1207-1211. PubMed ID: 34872103 [No Abstract] [Full Text] [Related]
8. SARS-CoV-2 vaccination in CLL: how often is enough? Mellinghoff SC; Cornely OA Blood; 2022 Dec; 140(25):2655-2657. PubMed ID: 36548017 [No Abstract] [Full Text] [Related]
9. SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia. Mellinghoff SC; Robrecht S; Mayer L; Weskamm LM; Dahlke C; Gruell H; Vanshylla K; Schlösser HA; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Eichhorst B; Hallek M; Langerbeins P Leukemia; 2022 Feb; 36(2):562-565. PubMed ID: 34937858 [No Abstract] [Full Text] [Related]
10. COVID-19 vaccine response in chronic lymphocytic leukaemia is more than just seroconversion. Sun C Br J Haematol; 2022 Apr; 197(1):11-12. PubMed ID: 35029303 [No Abstract] [Full Text] [Related]